She received her master’s degree cum laude in Medicinal Chemistry in 2021 at Sapienza University of Rome, with a thesis entitled "Alzheimer: synthesis of a NIR fluorescent BODIPY-based probe selective for the NFTs of tau protein". Currently, she is a PhD Student in Pharmaceutical Sciences at Sapienza University of Rome, under the supervision of Prof. Bruno Botta. Her research is mainly focused on the design and synthesis of bioconjugate linkers for the development of new delivery systems.

WG2a: inhibition of Hedgehog pathway

E-mail: lara.lamelza@uniroma1.it